Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
01/13/2011 | US20110009478 Theranostic polycation beacons comprising oligoethyleneamine repeating units and lanthanide chelates |
01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
01/13/2011 | US20110009467 Methods to Increase or Decrease Bone Density |
01/13/2011 | US20110008842 Novel chimeric tnf ligands |
01/13/2011 | US20110008839 Expression Vectors Comprising the MCMV IE2 Promoter |
01/13/2011 | US20110008792 Promoters for expression in modified vaccinia virus ankara |
01/13/2011 | CA2805403A1 Bioengineered silk protein-based nucleic acid delivery systems |
01/13/2011 | CA2804602A1 Codon-optimized factor viii variants and synthetic liver-specific promoter |
01/13/2011 | CA2803525A1 Aptamer-targeted sirna to inhibit nonsense mediated decay |
01/13/2011 | CA2767621A1 Sparc antisense compositions and uses thereof |
01/13/2011 | CA2767367A1 The use of two micrornas in lung cancer prognosis and drug preparation |
01/13/2011 | CA2767148A1 Process for the identification of compounds for treating cancer |
01/13/2011 | CA2765694A1 Amphoteric liposomes comprising imino lipids |
01/12/2011 | EP2272985A1 Antisense modulation of apolipoprotein (A) expression |
01/12/2011 | EP2272960A1 Human protein NELL2 gene |
01/12/2011 | EP2272950A2 Defective influenza virus particles |
01/12/2011 | EP2272857A1 Modulation of glucagon receptor expression |
01/12/2011 | EP2272529A2 DNA vaccine combined with an inducer of tumor cell apoptosis |
01/12/2011 | EP2272528A2 DNA vaccine combined with an inducer of tumor cell apoptosis |
01/12/2011 | EP2272527A2 Combined DNA vaccine and biological modifiers for cancer therapy |
01/12/2011 | EP2272526A2 Adjuvant for transcutaneous immunization |
01/12/2011 | EP2271768A2 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung |
01/12/2011 | EP2271370A2 Compositions and methods for diagnosing and treating melanoma |
01/12/2011 | EP2271369A1 Novel therapeutical tools and methods for treating blindness |
01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
01/12/2011 | EP1254951B1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method |
01/12/2011 | CN1826411B Promoter construct for gene expression in neuronal cells |
01/12/2011 | CN101946001A Polypeptide-nucleic acid conjugates and uses thereof |
01/12/2011 | CN101942481A Construction and application of recombined lentivirus vector aiming at RNA interference of PKC gamma genes |
01/12/2011 | CN101942475A Micro-loop free expression vector and construction method and application thereof |
01/12/2011 | CN101942444A Small RNA for human and rat-homologous NMDA receptor NR2B and application thereof |
01/12/2011 | CN101942443A Novel beta-actin and rps21 promoters and uses thereof |
01/12/2011 | CN101942442A Novel beta-actin and rps21 promoters and uses thereof |
01/12/2011 | CN101942441A Structure and application of siRNA for suppressing proliferation and metastasis of human lung cancer cells |
01/12/2011 | CN101942418A 333rd amino acid mutant strain of rabies virus Flury-LEP glycoprotein |
01/12/2011 | CN101942017A Novel tumor marker |
01/12/2011 | CN101940796A Preparation of gene immunization treating tumor used for vein |
01/12/2011 | CN101940795A Applications of DLK1 gene, siRNA (small interference Ribonucleic Acid), BM-MSCs (Bone Marrow Mesenchymal Stem Cells) and FGF2 (Fibroblast Growth Factor2) |
01/12/2011 | CN101940794A Csk binding protein inhibitor and application thereof |
01/12/2011 | CN101940786A Application of immunogenic protein gene PilA of haemophilus parasuis |
01/12/2011 | CN101940783A Application of DNAzyme in preparing medicines for enhancing tumor chemotherapy sensitivity |
01/12/2011 | CN101940551A Self-assembly nano-particles of sulfhydrylation chitosan quaternary ammonium salt and preparation method and application thereof |
01/12/2011 | CN101200483B Antisense nucleic acid of resistant and tolerant dimethoxyphenecillin staphylococcus aureus drug resistant gene |
01/12/2011 | CN101148473B Recombination human insulin and its coding gene and application |
01/11/2011 | US7868160 Compositions and methods for inhibiting expression of anti-apoptotic genes |
01/11/2011 | US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune |
01/11/2011 | US7867974 orally administering to a patient a therapeutically effective amount of factor VIII in water to induce oral tolerance and supply exogenous factor VIII ( not present in liposome), for increasing hemostasis in the patient having hemophilia A; obtained from milk of a non-human transgenic mammal |
01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
01/11/2011 | CA2309541C Vegi, an inhibitor of angiogenesis and tumor growth |
01/11/2011 | CA2286313C Novel ldl-receptor |
01/11/2011 | CA2263848C New systems for the regulation of gene expression |
01/06/2011 | WO2011002077A1 Tnf-α gene therapy agent contained in polymeric micelle |
01/06/2011 | WO2011002070A1 Pharmaceutical composition for treating iron overload disorders or diseases on which the reduction in iron concentration is effective, which comprises gdf7/bmp12 protein |
01/06/2011 | WO2011001882A1 Flagellin mutant capable of effectively inducing protective capability on infection by pseudomonas aeruginosa |
01/06/2011 | WO2010123699A3 Compositions, kits and methods for promoting ischemic and diabetic wound healing |
01/06/2011 | WO2010093904A3 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
01/06/2011 | WO2010033285A3 Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells |
01/06/2011 | US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase |
01/06/2011 | US20110003883 Allosteric trans-splicing group i ribozyme whose activity of target-specific rna replacement is controlled by theophylline |
01/06/2011 | US20110003381 Viral vectors and host cells and methods of making and using them |
01/06/2011 | US20110003378 MULTIPLE PROMOTER EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS |
01/06/2011 | US20110003318 Nucleotide and protein sequence of mammastatin and methods of use |
01/06/2011 | US20110003307 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
01/06/2011 | US20110002996 Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue |
01/06/2011 | US20110002980 Vaccines using nucleic acid-lipid complexes |
01/06/2011 | US20110002956 Mutant human cd80 and compositions for and methods of making and using the same |
01/06/2011 | US20110002953 Use of immidazoquinolinamines as adjuvants in dna vaccination |
01/06/2011 | US20110002919 Antagonists of neuropilin receptor function and use thereof |
01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
01/06/2011 | US20110002890 Treatment of tumors with genetically engineered herpes virus |
01/05/2011 | EP2270513A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
01/05/2011 | EP2270230A2 Antisense modulation of insulin-like growth factor binding protein 5 expression |
01/05/2011 | EP2270209A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
01/05/2011 | EP2270162A2 Conserved HBV and HCV sequences useful for gene silencing |
01/05/2011 | EP2270161A2 Multiple RNA polymerase III promoter expression constructs |
01/05/2011 | EP2270159A1 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
01/05/2011 | EP2270027A1 Polypeptides having brain-localizing activity and uses thereof |
01/05/2011 | EP2270024A1 Antisense modulation of superoxide dismutase 1, soluble expression |
01/05/2011 | EP2269658A1 Gene therapy for neurometabolic disorders |
01/05/2011 | EP2269628A2 Pancreas-specific proteins |
01/05/2011 | EP2269461A1 Treating cardiovascular tissue |
01/05/2011 | EP2268798A1 Method for obtaining ngn3-expressing cells and insulin producing-beta cells |
01/05/2011 | EP2268316A2 NOVEL siRNA COMPOUNDS FOR INHIBITING RTP801 |
01/05/2011 | EP1747023B1 Methods and compositions for reducing hcv viral genome amounts in a target cell |
01/05/2011 | EP1723417B1 C20orf23 as modifier of the igfr pathway and methods of use |
01/05/2011 | EP1706489B9 Oligomeric compounds for the modulation of bcl-2 |
01/05/2011 | EP1663315B1 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells |
01/05/2011 | EP1546322B1 Transposon-based vectors and methods of nucleic acid integration |
01/05/2011 | EP0815129B1 Ingap protein involved in pancreatic islet neogenesis |
01/05/2011 | CN1703229B Compositions and uses for treatment of prostate and other cancers |
01/05/2011 | CN101935687A Application of IL-12p40 siRNA to promoting liver regeneration |
01/05/2011 | CN101935674A Adenovirus vector for gene therapy on hemophilia B and application thereof |
01/05/2011 | CN101935673A Method for promoting liver regeneration by adjusting GAT-1 expression |
01/05/2011 | CN101935659A MiRNA for female ascaris suum adult specificity expression and application thereof |
01/05/2011 | CN101935658A MiRNA specially expressed in adult male ascaris suums and use thereof |
01/05/2011 | CN101935656A Gene for promoting insulin secretion, preparation method and application thereof |
01/05/2011 | CN101935651A siRNA module of targeted Survivin gene and application thereof |
01/05/2011 | CN101935650A siRNA (Small interfering Ribonucleic Acid) molecule for interfering Survivin expression and application thereof |
01/05/2011 | CN101935649A SiRNA (Small Interfering RNA) molecule capable of suppressing Survivin expression and application thereof |